Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2012

01-01-2012 | 2011 SSAT Plenary Presentation

Is It Worth Looking? Abdominal Imaging After Pancreatic Cancer Resection: a National Study

Authors: Elan R. Witkowski, Jillian K. Smith, Elizaveta Ragulin-Coyne, Sing-Chau Ng, Shimul A. Shah, Jennifer F. Tseng

Published in: Journal of Gastrointestinal Surgery | Issue 1/2012

Login to get access

Abstract

Introduction

Abdominal imaging is often performed after pancreatic cancer resection. We attempted to quantify the volume and estimate the cost of complex imaging after pancreatectomy nationwide, and to determine whether their frequent use confers benefit.

Methods

Patients with pancreatic adenocarcinoma who underwent resection were identified in Surveillance, Epidemiology and End Results–Medicare (1991–2005). Claims for abdominal imaging ≤5 years after resection were analyzed. Patients receiving annual CT scans were identified. Univariate and multivariate analyses were performed. To assess frequency of annual CT scanning in patients with superior survival, the top decile was further analyzed.

Results

Eleven thousand eight hundred fifty studies were performed on 2,217 patients. Ten thousand five hundred forty-two (89%) were CT scans. The median number of scans doubled from three in 1991 to six in 2005 (p < 0.0001). Among patients with sufficient survival to allow for analysis, 51.3% received annual CT scans, while only 32.4% of top-performing patients received annual scans. Univariate analysis of the 10% of patients with superior survival did not reveal any significant benefit associated with annual imaging.

Conclusion

Utilization of complex imaging after pancreatic cancer resection has increased substantially among Medicare beneficiaries, driven primarily by an increasing number of CT scans. Our study demonstrated no significant survival benefit among patients who received scans on a routine basis.
Literature
1.
go back to reference Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. May 2006;17(4):403–409.PubMedCrossRef Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. May 2006;17(4):403–409.PubMedCrossRef
2.
go back to reference Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. Aug 2007;246(2):173–180.PubMedCrossRef Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. Aug 2007;246(2):173–180.PubMedCrossRef
3.
go back to reference Carroll JE, Smith JK, Simons JP, et al. (2010) Redefining mortality after pancreatic cancer resection. J Gastrointest Surg 14(11):1701–1708.PubMedCrossRef Carroll JE, Smith JK, Simons JP, et al. (2010) Redefining mortality after pancreatic cancer resection. J Gastrointest Surg 14(11):1701–1708.PubMedCrossRef
4.
go back to reference Riall TS, Nealon WH, Goodwin JS, et al. Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg. Nov 2006;10(9):1212–1223; discussion 1223–1214.PubMedCrossRef Riall TS, Nealon WH, Goodwin JS, et al. Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg. Nov 2006;10(9):1212–1223; discussion 1223–1214.PubMedCrossRef
5.
go back to reference Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. Mar 2008;247(3):456–462.PubMedCrossRef Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. Mar 2008;247(3):456–462.PubMedCrossRef
6.
go back to reference Simons JP, Shah SA, Ng SC, Whalen GF, Tseng JF. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. Oct 2009;13(10):1798–1805.PubMedCrossRef Simons JP, Shah SA, Ng SC, Whalen GF, Tseng JF. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. Oct 2009;13(10):1798–1805.PubMedCrossRef
7.
go back to reference Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA. Apr 28 2010;303(16):1625–1631.PubMedCrossRef Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA. Apr 28 2010;303(16):1625–1631.PubMedCrossRef
9.
go back to reference Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. Aug 2002;40(8 Suppl):IV-55-61. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. Aug 2002;40(8 Suppl):IV-55-61.
10.
go back to reference Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008;8:12.PubMedCrossRef Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008;8:12.PubMedCrossRef
11.
go back to reference Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. Jun 1992;45(6):613–619.PubMedCrossRef Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. Jun 1992;45(6):613–619.PubMedCrossRef
12.
go back to reference Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. Dec 2000;53(12):1258–1267.PubMedCrossRef Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. Dec 2000;53(12):1258–1267.PubMedCrossRef
14.
go back to reference Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association. June 1958;53(282):457–481.CrossRef Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association. June 1958;53(282):457–481.CrossRef
15.
go back to reference Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical care. Aug 2002;40(8 Suppl):IV-104-117. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical care. Aug 2002;40(8 Suppl):IV-104-117.
16.
go back to reference Simons JP, Ng SC, McDade TP, Zhou Z, Earle CC, Tseng JF. Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices. Cancer. Apr 1 2010;116(7):1681–1690.PubMedCrossRef Simons JP, Ng SC, McDade TP, Zhou Z, Earle CC, Tseng JF. Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices. Cancer. Apr 1 2010;116(7):1681–1690.PubMedCrossRef
Metadata
Title
Is It Worth Looking? Abdominal Imaging After Pancreatic Cancer Resection: a National Study
Authors
Elan R. Witkowski
Jillian K. Smith
Elizaveta Ragulin-Coyne
Sing-Chau Ng
Shimul A. Shah
Jennifer F. Tseng
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 1/2012
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1699-z

Other articles of this Issue 1/2012

Journal of Gastrointestinal Surgery 1/2012 Go to the issue